Single vs Multi-fraction SRS Patients on Immunotherapy
NCT04427228 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2023-08-28
Summary
This study is meant to compare different surgical approaches to brain cancer.
Conditions
Interventions
- RADIATION
-
Radiosurgery Single Treatment
Frameless single-fraction SRS. One large treatment done on each brain tumor. 20 Gy for GTVs (or resection cavity CTVs) \< 2 cm, and 18 Gy for GTVs (or resection cavity CTVs) between 2-3 cm in the single-fraction.
- RADIATION
-
Radiosurgery Three Treatments
Multi-fraction SRS. Three small doses done on each brain tumor. 27 Gy in 3 fractions in the multi-fraction group
Sponsors & Collaborators
-
University of Chicago
lead OTHER
Principal Investigators
-
Steven Chmura, MD · University of Chicago
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-29
- Primary Completion
- 2022-12-12
- Completion
- 2022-12-12
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors
NCT03750227 ·Status: RECRUITING ·Phase: PHASE3
-
Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain Metastases
NCT02187822 ·Status: TERMINATED ·Phase: PHASE1
-
Dose Escalation Trial of Neoadjuvant Radiosurgery for the Treatment of Metastatic Brain Tumors
NCT03163368 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Radiation Therapy With or Without Surgery in Treating Patients Who Have Brain Metastases
NCT00003324 ·Status: COMPLETED ·Phase: NA
-
Trial of Differential Margins in Single Isocenter Radiosurgery of Brain Metastases
NCT06857006 ·Status: RECRUITING ·Phase: NA
-
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
NCT00030628 ·Status: COMPLETED ·Phase: PHASE3
-
Stereotactic Radiosurgery After Surgery in Treating Patients With Brain Metastases
NCT00814463 ·Status: TERMINATED ·Phase: PHASE2
-
Concurrent Azeliragon With Craniospinal Irradiation
NCT06724926 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma
NCT04477200 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Comparing the Addition of Radiation Either Before or After Surgery for Patients With Brain Metastases
NCT05438212 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Stereotactic Radiation Therapy Before Surgery for the Treatment of Resectable Brain Metastases
NCT04069910 ·Status: WITHDRAWN ·Phase: NA
-
Fractionated Stereotactic Radiosurgery With Concurrent Bevacizumab for Brain Metastases: A Phase I Dose-escalation Trial
NCT02672995 ·Status: UNKNOWN ·Phase: PHASE1
-
Stereotactic Radiosurgery or Whole Brain Radiation Therapy in Treating Patients With Newly Diagnosed Non-melanoma Brain Metastases
NCT01592968 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Surgery Versus Stereotactic Radiosurgery in the Treatment of Single Brain Metastasis: A Randomized Trial
NCT00460395 ·Status: COMPLETED ·Phase: PHASE3
-
Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory Meningioma
NCT03267836 ·Status: TERMINATED ·Phase: PHASE1
-
Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases
NCT05341349 ·Status: TERMINATED ·Phase: PHASE1
-
Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases That Have Been Removed By Surgery
NCT01372774 ·Status: COMPLETED ·Phase: PHASE3
-
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
NCT01622868 ·Status: COMPLETED ·Phase: PHASE2
-
EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active
NCT06649058 ·Status: RECRUITING ·Phase: PHASE2
-
Stereotactic Radiosurgery in Treating Patients With Brain Metastases
NCT00811655 ·Status: TERMINATED ·Phase: PHASE2
-
Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases
NCT03741673 ·Status: RECRUITING ·Phase: PHASE3
-
Radiation Therapy in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Grade II or Grade III Meningioma
NCT00626730 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase I Newly Diagnosed GBM With Temozolomide, Radiation, and Minocycline Followed by Adjuvant Minocycline/Temozolomide (D-TERMINED)
NCT02272270 ·Status: COMPLETED ·Phase: PHASE1
-
Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases
NCT06328686 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma
NCT00895622 ·Status: COMPLETED ·Phase: PHASE2